Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents

  • Bioorg Med Chem. 2015 Oct 1;23(19):6454-66. doi: 10.1016/j.bmc.2015.08.018.
Pritam Thapa  1 ,  Kyu-Yeon Jun  2 ,  Tara Man Kadayat  1 ,  Chanmi Park  2 ,  Zhi Zheng  3 ,  Til Bahadur Thapa Magar  1 ,  Ganesh Bist  1 ,  Aarajana Shrestha  1 ,  Younghwa Na  4 ,  Youngjoo Kwon  5 ,  Eung-Seok Lee  6
Affiliations
  • 1. College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea.
  • 2. College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Global Top 5 Program Ewha Womans University, Seoul 120-750, Republic of Korea.
  • 3. School of Public Health, Xinxiang Medical University, Henan 453003, China.
  • 4. College of Pharmacy, Cha University, Pochon 487-010, Republic of Korea.
  • 5. College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Global Top 5 Program Ewha Womans University, Seoul 120-750, Republic of Korea. Electronic address: [email protected].
  • 6. College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea. Electronic address: [email protected].
PMID: 26361737 DOI: 10.1016/j.bmc.2015.08.018
Abstract

To develop novel selective Topoisomerase II inhibitors, we designed and synthesized a series of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines and evaluated their Topoisomerase inhibitory activity and cytotoxicity against three human Cancer cell lines (DU145, HCT15, and T47D) and a normal cell line (MCF10A). All of the prepared compounds displayed stronger or similar Topoisomerase II inhibitory activity as well as cytotoxicity against three human Cancer cell lines compared to etoposide. Compounds 10a, 10g, 11a, 11f, 11g, 12a, 12f, and 12g especially showed stronger Topoisomerase II inhibitory activity as compared to etoposide at both 100 μM and 20 μM. A structure-activity relationship study revealed that hydroxyphenyl moiety at 4-position of pyridine and ortho-hydroxyphenyl or thienyl moiety at 2-position of pyridine has an important role in displaying selective Topoisomerase II inhibition. The compound 12b with para-hydroxyphenyl and meta-hydroxyphenyl at 4- and 2-position of pyridine, respectively, showed the most significant cytotoxicity against all three Cancer cell lines, whereas less cytotoxicity to a normal cell line as compared to adriamycin.

Keywords
Antiproliferative agents; Cytotoxicity; Hydroxylated 4-phenyl-2-aryl chromenopyridines; Structure–activity relationships; Topoisomerase II inhibitor.